TIMOLOL

TIMOLOL was reported 12180 times

TIMOLOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INFECTIOUS CRYSTALLINE KERATOPATHY 8 0.2162
1 HYPOTONY MACULOPATHY 7 0.1707
2 TOTAL LUNG CAPACITY INCREASED 26 0.0956
3 CONJUNCTIVAL SCAR 13 0.0861
4 CONJUNCTIVAL ULCER 6 0.0435
5 ALKALOSIS HYPOCHLORAEMIC 6 0.0429
6 ANTERIOR CHAMBER FIBRIN 5 0.0388
7 TREATMENT FAILURE 3052 0.0368
8 INTRAOCULAR PRESSURE DECREASED 19 0.0361
9 HYPOTONY OF EYE 15 0.0357
10 FLOPPY IRIS SYNDROME 13 0.0352
11 PEAK EXPIRATORY FLOW RATE DECREASED 14 0.0318
12 PRODUCT DROPPER ISSUE 24 0.0305
13 INTRAOCULAR PRESSURE FLUCTUATION 6 0.0305
14 VITREAL CELLS 6 0.0297
15 LUNG DIFFUSION TEST DECREASED 11 0.0276
16 IRIS ADHESIONS 14 0.0273
17 SHORT STATURE 7 0.0267
18 ADMINISTRATION SITE DISCOMFORT 5 0.0265
19 CHOROIDAL EFFUSION 19 0.0237
20 INTRAOCULAR PRESSURE TEST ABNORMAL 16 0.0227
21 INTRAOCULAR PRESSURE INCREASED 286 0.0224
22 FORCED VITAL CAPACITY DECREASED 14 0.0214
23 HAEMANGIOMA CONGENITAL 10 0.0211
24 RHINOCEREBRAL MUCORMYCOSIS 7 0.0202
25 CHOROIDAL DETACHMENT 11 0.0198
26 POSTERIOR CAPSULE OPACIFICATION 6 0.0175
27 INJURY CORNEAL 9 0.0173
28 CORNEAL OEDEMA 37 0.0165
29 HYPHAEMA 8 0.0153
30 ANTERIOR CHAMBER INFLAMMATION 9 0.0151
31 REACTION TO PRESERVATIVES 12 0.0147
32 ELECTROLYTE DEPLETION 7 0.0142
33 GROWTH OF EYELASHES 11 0.0139
34 CATARACT NUCLEAR 9 0.0135
35 CYSTOID MACULAR OEDEMA 24 0.0127
36 KERATIC PRECIPITATES 6 0.0126
37 GLAUCOMA 237 0.0123
38 CORNEAL EPITHELIUM DEFECT 7 0.0120
39 PUNCTATE KERATITIS 11 0.0120
40 GLARE 6 0.0117
41 CATARACT SUBCAPSULAR 7 0.0115
42 ANTERIOR CHAMBER CELL 8 0.0112
43 OPTIC NERVE INJURY 13 0.0112
44 VITAMIN B12 DECREASED 32 0.0111
45 CONJUNCTIVAL HYPERAEMIA 39 0.0109
46 OCULAR HYPERTENSION 21 0.0108
47 CORNEAL DEPOSITS 8 0.0108
48 ANGLE CLOSURE GLAUCOMA 27 0.0106
49 RETINAL PIGMENTATION 8 0.0102
50 EYELID MARGIN CRUSTING 29 0.0100
51 FORCED EXPIRATORY VOLUME DECREASED 28 0.0099
52 IRIDOCYCLITIS 29 0.0092
53 CORNEAL DISORDER 20 0.0091
54 EYE ALLERGY 14 0.0090
55 MACULAR FIBROSIS 6 0.0088
56 FOREIGN BODY IN EYE 8 0.0083
57 NON-INFECTIOUS ENDOPHTHALMITIS 7 0.0082
58 SUBRETINAL FLUID 9 0.0082
59 EYELID PAIN 16 0.0079
60 FOREIGN BODY SENSATION IN EYES 50 0.0078
61 RETINAL EXUDATES 7 0.0075
62 TOXIC ANTERIOR SEGMENT SYNDROME 8 0.0073
63 CORNEAL OPACITY 10 0.0073
64 SUPERFICIAL INJURY OF EYE 8 0.0073
65 RETINAL DISORDER 19 0.0073
66 HYPOPYON 6 0.0072
67 ULCERATIVE KERATITIS 19 0.0069
68 ENDOCRINE OPHTHALMOPATHY 6 0.0069
69 PRODUCT CLOSURE REMOVAL DIFFICULT 7 0.0069
70 VITREOUS HAEMORRHAGE 18 0.0065
71 PRODUCT CONTAINER ISSUE 55 0.0064
72 EYE IRRITATION 362 0.0063
73 NODAL RHYTHM 9 0.0061
74 ALTERED VISUAL DEPTH PERCEPTION 5 0.0061
75 EYE COLOUR CHANGE 6 0.0059
76 NEPHROGENIC ANAEMIA 27 0.0058
77 HYPERPARATHYROIDISM SECONDARY 14 0.0056
78 EYE PAIN 312 0.0055
79 DARK CIRCLES UNDER EYES 8 0.0054
80 OCULAR DISCOMFORT 60 0.0053
81 INSTILLATION SITE IRRITATION 6 0.0051
82 BLEPHARITIS 20 0.0050
83 IRITIS 15 0.0049
84 CARDIOVASCULAR INSUFFICIENCY 8 0.0049
85 VITRITIS 9 0.0049
86 OCULAR HYPERAEMIA 230 0.0048
87 EYE PRURITUS 157 0.0047
88 RETINAL DEGENERATION 6 0.0046
89 EYE INFLAMMATION 44 0.0046
90 HERPES OPHTHALMIC 6 0.0045
91 MACULAR OEDEMA 25 0.0045
92 OPHTHALMIC HERPES ZOSTER 8 0.0044
93 ERYTHEMA OF EYELID 24 0.0044
94 KERATOPATHY 7 0.0044
95 RESPIRATION ABNORMAL 30 0.0043
96 LACRIMATION INCREASED 131 0.0043
97 ATRIOVENTRICULAR BLOCK SECOND DEGREE 13 0.0043
98 KERATITIS 13 0.0043
99 EYE DISCHARGE 44 0.0042
100 VITREOUS DETACHMENT 9 0.0041
101 SEBORRHOEIC KERATOSIS 6 0.0041
102 FRUSTRATION TOLERANCE DECREASED 33 0.0041
103 NORMOCYTIC ANAEMIA 6 0.0041
104 CONJUNCTIVITIS ALLERGIC 6 0.0040
105 EYELID IRRITATION 10 0.0040
106 RETINAL DETACHMENT 36 0.0039
107 HAEMANGIOMA 9 0.0039
108 VOLVULUS 9 0.0038
109 METAMORPHOPSIA 7 0.0038
110 EYE OEDEMA 9 0.0037
111 RETINAL OEDEMA 7 0.0037
112 BLINDNESS UNILATERAL 51 0.0036
113 ABNORMAL SENSATION IN EYE 15 0.0035
114 CHOREA 6 0.0035
115 UVEITIS 47 0.0035
116 ENDOPHTHALMITIS 20 0.0033
117 LUNG ADENOCARCINOMA 10 0.0033
118 ADHESION 5 0.0033
119 REBOUND ACID HYPERSECRETION 10 0.0033
120 AGE-RELATED MACULAR DEGENERATION 5 0.0033
121 VITREOUS FLOATERS 32 0.0033
122 INSTILLATION SITE PAIN 8 0.0032
123 EYE HAEMORRHAGE 43 0.0032
124 BLOOD PRESSURE DIASTOLIC ABNORMAL 8 0.0031
125 CONJUNCTIVAL HAEMORRHAGE 12 0.0031
126 VISUAL ACUITY REDUCED 104 0.0031
127 VISUAL FIELD DEFECT 22 0.0030
128 WEIGHT BEARING DIFFICULTY 8 0.0030
129 OBSTRUCTIVE AIRWAYS DISORDER 33 0.0030
130 CATARACT 175 0.0029
131 PULMONARY THROMBOSIS 32 0.0029
132 PHOTOPHOBIA 54 0.0029
133 RETINAL TEAR 7 0.0028
134 EYE INFECTION 32 0.0028
135 BUNDLE BRANCH BLOCK RIGHT 13 0.0028
136 EYE OPERATION 13 0.0028
137 BRADYCARDIA 149 0.0028
138 EXPOSED BONE IN JAW 6 0.0028
139 MACULAR DEGENERATION 33 0.0028
140 DIVERTICULUM INTESTINAL 12 0.0027
141 CATHETER SITE PAIN 7 0.0027
142 ACTINIC KERATOSIS 7 0.0027
143 ATRIOVENTRICULAR BLOCK COMPLETE 18 0.0027
144 EYE INJURY 8 0.0026
145 SMALL FOR DATES BABY 13 0.0026
146 EYELID DISORDER 6 0.0026
147 BLINDNESS 104 0.0025
148 SWELLING OF EYELID 16 0.0025
149 MYOPIA 6 0.0025
150 BLOOD CREATINE INCREASED 11 0.0025
151 HYPERSENSITIVITY 461 0.0025
152 END STAGE RENAL DISEASE 45 0.0025
153 BLOOD PRESSURE SYSTOLIC ABNORMAL 6 0.0024
154 BLOOD PRESSURE SYSTOLIC INCREASED 47 0.0024
155 VENTRICULAR HYPERTROPHY 6 0.0024
156 HYPOTHERMIA 24 0.0024
157 PRODUCT PHYSICAL CONSISTENCY ISSUE 13 0.0023
158 LIQUID PRODUCT PHYSICAL ISSUE 17 0.0023
159 ATRIOVENTRICULAR BLOCK 18 0.0023
160 DRY EYE 116 0.0023
161 EYE DISORDER 76 0.0023
162 HYPOPNOEA 8 0.0023
163 EYE SWELLING 85 0.0023
164 PIGMENTATION DISORDER 14 0.0023
165 EYELIDS PRURITUS 7 0.0022
166 URINE ODOUR ABNORMAL 13 0.0022
167 HYPERKERATOSIS 12 0.0022
168 VISION BLURRED 297 0.0022
169 SKIN HYPERTROPHY 6 0.0021
170 PROSTATE CANCER METASTATIC 7 0.0021
171 LIP PAIN 6 0.0021
172 POTENTIATING DRUG INTERACTION 7 0.0021
173 COMA SCALE ABNORMAL 6 0.0021
174 ESCHERICHIA SEPSIS 6 0.0021
175 TONGUE DISCOLOURATION 9 0.0021
176 CONJUNCTIVITIS 38 0.0020
177 BLINDNESS TRANSIENT 15 0.0020
178 ASTHENOPIA 11 0.0020
179 MACULOPATHY 7 0.0020
180 SINUS BRADYCARDIA 19 0.0020
181 BODY HEIGHT DECREASED 21 0.0020
182 CATATONIA 10 0.0019
183 RETINOPATHY 7 0.0019
184 LOOSE TOOTH 6 0.0019
185 PRODUCT DELIVERY MECHANISM ISSUE 10 0.0019
186 ONYCHOMYCOSIS 8 0.0018
187 SUPRAVENTRICULAR EXTRASYSTOLES 6 0.0018
188 EYELID PTOSIS 18 0.0018
189 PERIORBITAL SWELLING 10 0.0018
190 HYPERLIPIDAEMIA 21 0.0018
191 PSYCHOLOGICAL TRAUMA 15 0.0017
192 ORTHOSTATIC HYPOTENSION 30 0.0017
193 TRIGGER FINGER 7 0.0017
194 VISUAL IMPAIRMENT 211 0.0017
195 RETINAL HAEMORRHAGE 12 0.0017
196 HYPERKALAEMIA 58 0.0017
197 RENAL CYST 13 0.0016
198 GASTRIC ULCER HAEMORRHAGE 9 0.0016
199 UPPER GASTROINTESTINAL HAEMORRHAGE 27 0.0016
200 PROSTATIC SPECIFIC ANTIGEN INCREASED 22 0.0016
201 PARONYCHIA 7 0.0016
202 LARGE INTESTINE POLYP 11 0.0016
203 PRODUCT USE COMPLAINT 25 0.0016
204 PHOTOPSIA 10 0.0016
205 PERIPHERAL VASCULAR DISORDER 8 0.0016
206 THERAPEUTIC PRODUCT INEFFECTIVE 6 0.0016
207 EYELID OEDEMA 18 0.0015
208 PULMONARY MASS 23 0.0015
209 FAECES HARD 6 0.0015
210 HAEMATEMESIS 39 0.0015
211 PROSTATOMEGALY 6 0.0015
212 UROSEPSIS 14 0.0015
213 IRON DEFICIENCY ANAEMIA 14 0.0015
214 PERSONALITY CHANGE 14 0.0015
215 SPINAL COLUMN STENOSIS 7 0.0015
216 PRODUCT LABEL ISSUE 10 0.0015
217 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 6 0.0015
218 MADAROSIS 17 0.0015
219 HAIR DISORDER 12 0.0015
220 ATELECTASIS 14 0.0014
221 AORTIC STENOSIS 5 0.0014
222 SKIN PLAQUE 12 0.0014
223 INCONTINENCE 15 0.0014
224 CARDIAC FAILURE CHRONIC 6 0.0014
225 IMPAIRED DRIVING ABILITY 16 0.0014
226 INTERVERTEBRAL DISC DEGENERATION 13 0.0014
227 PRODUCT DISPENSING ISSUE 6 0.0014
228 LEFT VENTRICULAR HYPERTROPHY 6 0.0014
229 HAEMOGLOBIN ABNORMAL 9 0.0014
230 DRY MOUTH 113 0.0014
231 HORDEOLUM 6 0.0014
232 SQUAMOUS CELL CARCINOMA 13 0.0014
233 SUBARACHNOID HAEMORRHAGE 14 0.0014
234 HALLUCINATION, VISUAL 29 0.0014
235 HAIR COLOUR CHANGES 17 0.0014
236 WALKING AID USER 9 0.0014
237 PRODUCT COLOUR ISSUE 7 0.0014
238 LOWER GASTROINTESTINAL HAEMORRHAGE 10 0.0014
239 GLUCOSE TOLERANCE IMPAIRED 8 0.0014
240 WHEELCHAIR USER 6 0.0013
241 CATARACT OPERATION 8 0.0013
242 ESCHERICHIA INFECTION 11 0.0013
243 SUBDURAL HAEMATOMA 19 0.0013
244 PEMPHIGOID 10 0.0013
245 HOSPICE CARE 13 0.0013
246 EYE MOVEMENT DISORDER 9 0.0013
247 HIATUS HERNIA 17 0.0013
248 DISEASE COMPLICATION 6 0.0013
249 EAR DISORDER 6 0.0013
250 LUMBAR VERTEBRAL FRACTURE 6 0.0013
251 GASTROINTESTINAL MOTILITY DISORDER 7 0.0013
252 HYPOTONIA 13 0.0013
253 HEAD INJURY 41 0.0013
254 CHRONIC KIDNEY DISEASE 98 0.0013
255 APNOEA 10 0.0013
256 PRE-EXISTING CONDITION IMPROVED 8 0.0013
257 DIVERTICULUM 9 0.0013
258 RED BLOOD CELL SEDIMENTATION RATE INCREASED 14 0.0013
259 BACTERAEMIA 15 0.0013
260 MEDICATION RESIDUE PRESENT 6 0.0013
261 ACUTE KIDNEY INJURY 192 0.0013
262 TUMOUR MARKER INCREASED 6 0.0012
263 MYDRIASIS 16 0.0012
264 NOCTURIA 15 0.0012
265 MYOSITIS 11 0.0012
266 HEART RATE DECREASED 43 0.0012
267 DIABETIC NEUROPATHY 6 0.0012
268 CORONAVIRUS INFECTION 8 0.0012
269 ARTERIOSCLEROSIS CORONARY ARTERY 8 0.0012
270 HYPONATRAEMIA 68 0.0012
271 RALES 7 0.0012
272 EMPHYSEMA 12 0.0012
273 PATHOLOGICAL FRACTURE 6 0.0012
274 NEPHROPATHY 11 0.0012
275 AORTIC VALVE INCOMPETENCE 5 0.0012
276 ARTERIOSCLEROSIS 11 0.0012
277 ROTATOR CUFF SYNDROME 15 0.0012
278 VARICOSE VEIN 6 0.0012
279 ARRHYTHMIA 55 0.0012
280 HAEMORRHAGIC STROKE 9 0.0012
281 HYPOMAGNESAEMIA 16 0.0011
282 DERMATITIS CONTACT 13 0.0011
283 CONCOMITANT DISEASE AGGRAVATED 7 0.0011
284 VERTIGO 69 0.0011
285 ABDOMINAL ABSCESS 5 0.0011
286 TRANSIENT ISCHAEMIC ATTACK 38 0.0011
287 INTERNATIONAL NORMALISED RATIO INCREASED 32 0.0011
288 HAIR TEXTURE ABNORMAL 15 0.0011
289 BLOOD COUNT ABNORMAL 17 0.0011
290 ELECTROLYTE IMBALANCE 13 0.0011
291 GASTROINTESTINAL INFECTION 10 0.0011
292 SHOCK HAEMORRHAGIC 9 0.0011
293 FAECES SOFT 8 0.0011
294 SALIVARY HYPERSECRETION 11 0.0011
295 FULL BLOOD COUNT DECREASED 22 0.0011
296 MELAENA 24 0.0011
297 INCOHERENT 7 0.0011
298 HELICOBACTER INFECTION 11 0.0011
299 PRESYNCOPE 26 0.0011
300 POLYP 7 0.0011
301 SENSATION OF FOREIGN BODY 9 0.0011
302 LACERATION 10 0.0011
303 GOUT 19 0.0011
304 PRODUCT PACKAGING ISSUE 10 0.0011
305 ATRIAL FIBRILLATION 102 0.0010
306 HYPOACUSIS 45 0.0010
307 FEELING COLD 29 0.0010
308 RENAL FAILURE CHRONIC 8 0.0010
309 HYPOKALAEMIA 48 0.0010
310 OSTEOARTHRITIS 44 0.0010
311 HALLUCINATION 78 0.0010
312 CONFUSIONAL STATE 167 0.0010
313 DIZZINESS POSTURAL 10 0.0010
314 HAEMORRHOIDS 20 0.0010
315 GROIN PAIN 9 0.0010
316 SPINAL OSTEOARTHRITIS 9 0.0010
317 PERIPHERAL COLDNESS 14 0.0010
318 SINUS HEADACHE 6 0.0010
319 NASAL DISCOMFORT 8 0.0010
320 OESOPHAGITIS 11 0.0010
321 ANEURYSM 5 0.0010
322 ARTHRITIS 79 0.0010
323 APPLICATION SITE SWELLING 5 0.0010
324 EXTRASYSTOLES 7 0.0010
325 ATRIAL FLUTTER 8 0.0010
326 MASS 14 0.0010
327 TINNITUS 46 0.0010
328 WRIST FRACTURE 12 0.0010
329 HEARING IMPAIRED 6 0.0010
330 TOOTH FRACTURE 11 0.0010
331 FALL 332 0.0010
332 BALANCE DISORDER 86 0.0010
333 GASTROINTESTINAL HAEMORRHAGE 83 0.0010
334 INGUINAL HERNIA 6 0.0010
335 POST PROCEDURAL INFECTION 8 0.0010
336 HEART RATE IRREGULAR 22 0.0010
337 SKIN ULCER 25 0.0010
338 DEPRESSED MOOD 51 0.0010
339 EXPIRED PRODUCT ADMINISTERED 32 0.0010
340 BLOOD PRESSURE FLUCTUATION 23 0.0010
341 TRANSFUSION 10 0.0010
342 GINGIVAL BLEEDING 13 0.0010
343 SPINAL DISORDER 9 0.0009
344 BLOOD PRESSURE DIASTOLIC DECREASED 7 0.0009
345 BLOOD URINE PRESENT 18 0.0009
346 MUSCLE ATROPHY 12 0.0009
347 FACIAL PARALYSIS 8 0.0009
348 HAEMORRHAGE INTRACRANIAL 14 0.0009
349 HYDRONEPHROSIS 7 0.0009
350 UNRESPONSIVE TO STIMULI 24 0.0009
351 PARANOIA 16 0.0009
352 BOWEL MOVEMENT IRREGULARITY 7 0.0009
353 ANGINA PECTORIS 26 0.0009
354 TUBULOINTERSTITIAL NEPHRITIS 17 0.0009
355 HAEMATOCHEZIA 50 0.0009
356 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 8 0.0009
357 LOW DENSITY LIPOPROTEIN INCREASED 7 0.0009
358 DENTAL CARIES 10 0.0009
359 BLOOD SODIUM DECREASED 17 0.0009
360 LOWER RESPIRATORY TRACT INFECTION 41 0.0009
361 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 47 0.0009
362 PELVIC FRACTURE 7 0.0009
363 DEMENTIA 25 0.0009
364 SKIN DISCOLOURATION 41 0.0009
365 PRODUCT ADMINISTRATION INTERRUPTED 7 0.0009
366 ANAL INCONTINENCE 8 0.0009
367 CONTUSION 85 0.0009
368 SKIN CANCER 19 0.0009
369 ULCER 14 0.0009
370 ERUCTATION 17 0.0009
371 RIB FRACTURE 18 0.0009
372 INTERVERTEBRAL DISC PROTRUSION 19 0.0009
373 LETHARGY 50 0.0009
374 BLOOD POTASSIUM DECREASED 26 0.0009
375 SWOLLEN TONGUE 27 0.0009
376 DELIRIUM 30 0.0009
377 MUSCLE DISORDER 7 0.0009
378 POST PROCEDURAL HAEMORRHAGE 10 0.0009
379 ERECTILE DYSFUNCTION 22 0.0009
380 DEFAECATION URGENCY 6 0.0009
381 RENAL PAIN 9 0.0008
382 ACUTE CORONARY SYNDROME 7 0.0008
383 DEVICE RELATED INFECTION 13 0.0008
384 BURNING SENSATION 59 0.0008
385 PRODUCT ADMINISTRATION ERROR 17 0.0008
386 COAGULOPATHY 14 0.0008
387 RECALLED PRODUCT ADMINISTERED 8 0.0008
388 SLEEP APNOEA SYNDROME 16 0.0008
389 DRUG INTERACTION 133 0.0008
390 DELUSION 13 0.0008
391 PRODUCT AVAILABILITY ISSUE 19 0.0008
392 DIZZINESS 415 0.0008
393 CONSTIPATION 181 0.0008
394 SKIN LACERATION 9 0.0008
395 URINARY TRACT INFECTION 141 0.0008
396 DEHYDRATION 110 0.0008
397 MAJOR DEPRESSION 6 0.0008
398 MUSCULOSKELETAL PAIN 43 0.0008
399 VITAMIN D DECREASED 7 0.0008
400 GASTROINTESTINAL PAIN 9 0.0008
401 HAEMATURIA 28 0.0008
402 RENAL TUBULAR NECROSIS 8 0.0008
403 ENCEPHALOPATHY 20 0.0008
404 SINUS CONGESTION 11 0.0008
405 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 39 0.0008
406 DERMATITIS 17 0.0008
407 BLOOD MAGNESIUM DECREASED 7 0.0008
408 CEREBRAL DISORDER 6 0.0008
409 HYPERCALCAEMIA 10 0.0008
410 PULMONARY OEDEMA 36 0.0008
411 NASAL CONGESTION 47 0.0008
412 RENAL FAILURE 106 0.0008
413 GRIP STRENGTH DECREASED 7 0.0008
414 LUNG INFILTRATION 7 0.0008
415 ANAEMIA 151 0.0008
416 HEAD DISCOMFORT 14 0.0008
417 HUNGER 11 0.0008
418 APHONIA 11 0.0008
419 HYPOTENSION 158 0.0008
420 PHOTOSENSITIVITY REACTION 13 0.0008
421 DRY THROAT 8 0.0008
422 HYPOPHAGIA 20 0.0008
423 PULMONARY FIBROSIS 15 0.0008
424 SKIN REACTION 11 0.0008
425 EAR DISCOMFORT 8 0.0008
426 DECREASED APPETITE 181 0.0008
427 HYPERTENSION 165 0.0008
428 BLOOD PRESSURE INCREASED 119 0.0008
429 HIP FRACTURE 25 0.0008
430 OROPHARYNGEAL DISCOMFORT 7 0.0008
431 OSTEOMYELITIS 14 0.0008
432 PRODUCT QUALITY ISSUE 105 0.0008
433 BLOOD CHOLESTEROL INCREASED 36 0.0008
434 ACUTE MYELOID LEUKAEMIA 12 0.0008
435 POLLAKIURIA 32 0.0008
436 EXOSTOSIS 7 0.0008
437 IMPAIRED QUALITY OF LIFE 11 0.0008
438 DEAFNESS 20 0.0008
439 ELECTROCARDIOGRAM ABNORMAL 6 0.0008
440 ARTERIAL OCCLUSIVE DISEASE 6 0.0008
441 INCREASED TENDENCY TO BRUISE 7 0.0008
442 ANOSMIA 11 0.0008
443 BLOOD IRON DECREASED 9 0.0008
444 FLATULENCE 43 0.0008
445 RASH PRURITIC 41 0.0008
446 SUDDEN DEATH 8 0.0008
447 TRICUSPID VALVE INCOMPETENCE 6 0.0008
448 BLOOD PRESSURE ABNORMAL 15 0.0008
449 GASTROENTERITIS 11 0.0008
450 DYSPHONIA 44 0.0008
451 LIP SWELLING 25 0.0007
452 BACTERIAL INFECTION 14 0.0007
453 HAEMOGLOBIN DECREASED 77 0.0007
454 SYNCOPE 75 0.0007
455 DIARRHOEA HAEMORRHAGIC 7 0.0007
456 CARDIAC FAILURE CONGESTIVE 60 0.0007
457 RHINITIS 6 0.0007
458 MUSCLE TIGHTNESS 12 0.0007
459 FEEDING DISORDER 15 0.0007
460 LIMB INJURY 20 0.0007
461 DRUG INTOLERANCE 71 0.0007
462 PERIPHERAL SWELLING 113 0.0007
463 HAEMATOMA 19 0.0007
464 POLYURIA 6 0.0007
465 GAIT DISTURBANCE 140 0.0007
466 ABASIA 18 0.0007
467 UPPER-AIRWAY COUGH SYNDROME 6 0.0007
468 SPINAL COMPRESSION FRACTURE 6 0.0007
469 NIGHTMARE 25 0.0007
470 BLOOD PRESSURE DECREASED 48 0.0007
471 JOINT SWELLING 87 0.0007
472 GASTROOESOPHAGEAL REFLUX DISEASE 58 0.0007
473 ORAL DISCOMFORT 10 0.0007
474 DERMATITIS ALLERGIC 9 0.0007
475 PHARYNGEAL SWELLING 7 0.0007
476 CONDITION AGGRAVATED 217 0.0007
477 THYROID DISORDER 11 0.0007
478 BODY TEMPERATURE DECREASED 7 0.0007
479 MUSCULOSKELETAL CHEST PAIN 11 0.0007
480 LIGAMENT SPRAIN 7 0.0007
481 LYMPHOPENIA 10 0.0007
482 RENAL INJURY 21 0.0007
483 MITRAL VALVE INCOMPETENCE 8 0.0007
484 PLEURAL EFFUSION 43 0.0007
485 HAEMATOCRIT DECREASED 14 0.0007
486 BASAL CELL CARCINOMA 11 0.0007
487 INABILITY TO AFFORD MEDICATION 7 0.0007
488 ASTHENIA 265 0.0007
489 SCAB 8 0.0007
490 BRONCHOSPASM 10 0.0007
491 PSEUDOMONAS INFECTION 6 0.0007
492 CYANOSIS 11 0.0007
493 HEPATIC STEATOSIS 13 0.0007
494 OEDEMA PERIPHERAL 85 0.0007
495 POOR QUALITY SLEEP 15 0.0007
496 RHINORRHOEA 45 0.0007
497 DIPLOPIA 18 0.0007
498 PLATELET COUNT INCREASED 9 0.0007
499 SCIATICA 11 0.0007
500 COUGH 193 0.0007
501 GAIT INABILITY 23 0.0007
502 CLOSTRIDIUM DIFFICILE INFECTION 15 0.0007
503 URINE OUTPUT DECREASED 6 0.0007
504 DIVERTICULITIS 19 0.0007
505 RENAL FAILURE ACUTE 29 0.0007
506 SPINAL PAIN 8 0.0007
507 HYPOXIA 24 0.0007
508 AGEUSIA 17 0.0007
509 ABDOMINAL DISTENSION 71 0.0007
510 LOSS OF CONSCIOUSNESS 87 0.0007
511 MYALGIA 115 0.0007
512 ACUTE RESPIRATORY FAILURE 13 0.0007
513 RASH ERYTHEMATOUS 32 0.0007
514 DIABETES MELLITUS 51 0.0007
515 RED BLOOD CELL COUNT DECREASED 19 0.0007
516 DYSPHAGIA 63 0.0007
517 HYPOAESTHESIA ORAL 10 0.0007
518 LEUKOCYTOSIS 12 0.0007
519 TOOTHACHE 12 0.0007
520 CLOSTRIDIUM DIFFICILE COLITIS 7 0.0007
521 BURSITIS 8 0.0007
522 OSTEOPENIA 10 0.0007
523 BONE DISORDER 12 0.0007
524 EATING DISORDER 14 0.0007
525 DRUG DISPENSING ERROR 10 0.0007
526 UPPER LIMB FRACTURE 13 0.0007
527 NEUROPATHY PERIPHERAL 62 0.0007
528 DRUG ADMINISTRATION ERROR 20 0.0007
529 NERVOUSNESS 34 0.0007
530 DYSSTASIA 19 0.0007
531 CARDIOMEGALY 8 0.0006
532 DYSPNOEA 368 0.0006
533 WEIGHT DECREASED 181 0.0006
534 LIMB DISCOMFORT 20 0.0006
535 ANKLE FRACTURE 10 0.0006
536 CIRCULATORY COLLAPSE 11 0.0006
537 ASTHMA 73 0.0006
538 APHTHOUS ULCER 5 0.0006
539 CARPAL TUNNEL SYNDROME 9 0.0006
540 CEREBRAL HAEMORRHAGE 23 0.0006
541 MUSCULAR WEAKNESS 73 0.0006
542 DEFORMITY 6 0.0006
543 URINARY INCONTINENCE 19 0.0006
544 MOBILITY DECREASED 46 0.0006
545 MUSCULOSKELETAL DISCOMFORT 11 0.0006
546 SLEEP DISORDER 45 0.0006
547 DYSARTHRIA 24 0.0006
548 INJECTION SITE NODULE 7 0.0006
549 HYPOAESTHESIA 95 0.0006
550 GLYCOSYLATED HAEMOGLOBIN INCREASED 16 0.0006
551 DIARRHOEA 409 0.0006
552 FATIGUE 493 0.0006
553 DEPRESSED LEVEL OF CONSCIOUSNESS 25 0.0006
554 ACCIDENTAL EXPOSURE TO PRODUCT 65 0.0006
555 URINARY RETENTION 21 0.0006
556 CYSTITIS 20 0.0006
557 HYPERSOMNIA 18 0.0006
558 CORONARY ARTERY DISEASE 19 0.0006
559 METABOLIC ACIDOSIS 20 0.0006
560 GLOSSODYNIA 14 0.0006
561 ORAL PAIN 14 0.0006
562 DYSURIA 23 0.0006
563 PNEUMONITIS 17 0.0006
564 ERYTHEMA 128 0.0006
565 DRUG INEFFECTIVE 817 0.0006
566 SOMNOLENCE 124 0.0006
567 FEMUR FRACTURE 19 0.0006
568 MICTURITION URGENCY 7 0.0006
569 PRODUCT DOSE OMISSION 40 0.0006
570 KIDNEY INFECTION 12 0.0006
571 HOT FLUSH 46 0.0006
572 KNEE OPERATION 6 0.0006
573 METASTASES TO BONE 10 0.0006
574 JOINT INJURY 13 0.0006
575 GASTRITIS 16 0.0006
576 MANIA 10 0.0006
577 SKIN HAEMORRHAGE 9 0.0006
578 DISCOMFORT 37 0.0006
579 RECTAL HAEMORRHAGE 26 0.0006
580 INCORRECT DOSE ADMINISTERED 138 0.0006
581 BLADDER DISORDER 6 0.0006
582 EXTRAPYRAMIDAL DISORDER 15 0.0006
583 THROAT IRRITATION 27 0.0006
584 EPISTAXIS 45 0.0006
585 BRAIN INJURY 6 0.0006
586 MALIGNANT MELANOMA 8 0.0006
587 THROMBOSIS 48 0.0006
588 QUALITY OF LIFE DECREASED 8 0.0006
589 INTENTIONAL DOSE OMISSION 17 0.0006
590 EXTRA DOSE ADMINISTERED 24 0.0006
591 TASTE DISORDER 12 0.0006
592 OEDEMA 32 0.0006
593 ATAXIA 7 0.0006
594 TOOTH ABSCESS 6 0.0006
595 MIDDLE INSOMNIA 11 0.0006
596 SWELLING 55 0.0006
597 HIP ARTHROPLASTY 9 0.0006
598 PHARYNGEAL OEDEMA 9 0.0006
599 AMNESIA 38 0.0006
600 OSTEOPOROSIS 24 0.0006
601 CORONARY ARTERY OCCLUSION 8 0.0006
602 LYMPHOMA 9 0.0006
603 THYROID CANCER 7 0.0006
604 HYPOCALCAEMIA 11 0.0006
605 ABNORMAL DREAMS 16 0.0006
606 GASTRIC ULCER 11 0.0006
607 THERAPY NON-RESPONDER 26 0.0006
608 COGNITIVE DISORDER 27 0.0006
609 PAIN IN EXTREMITY 170 0.0006
610 BACK PAIN 134 0.0006
611 PROCEDURAL PAIN 16 0.0006
612 CHROMATURIA 13 0.0006
613 TENDERNESS 6 0.0006
614 PETECHIAE 6 0.0006
615 WEIGHT FLUCTUATION 6 0.0006
616 CARDIAC FAILURE 46 0.0006
617 PRODUCT ODOUR ABNORMAL 6 0.0006
618 APPLICATION SITE ERYTHEMA 15 0.0006
619 MOUTH ULCERATION 12 0.0006
620 BLOOD TEST ABNORMAL 8 0.0006
621 POOR QUALITY PRODUCT ADMINISTERED 6 0.0006
622 FEELING ABNORMAL 136 0.0006
623 INSOMNIA 151 0.0006
624 NEPHROLITHIASIS 26 0.0006
625 BLOOD TRIGLYCERIDES INCREASED 10 0.0006
626 PRODUCTIVE COUGH 27 0.0006
627 GENERALISED OEDEMA 7 0.0006
628 SEASONAL ALLERGY 8 0.0006
629 CHOKING 11 0.0006
630 PNEUMONIA 182 0.0006
631 CONTRAINDICATED PRODUCT ADMINISTERED 17 0.0006
632 STOMATITIS 34 0.0006
633 ISCHAEMIC STROKE 10 0.0006
634 THIRST 10 0.0006
635 FEAR 15 0.0006
636 DECREASED ACTIVITY 6 0.0006
637 PRURITUS GENERALISED 12 0.0006
638 BRONCHITIS 41 0.0006
639 FAECES DISCOLOURED 12 0.0006
640 MEMORY IMPAIRMENT 76 0.0006
641 DYSGEUSIA 41 0.0006
642 TACHYCARDIA 49 0.0006
643 BLOOD CREATININE INCREASED 36 0.0006
644 CHEST PAIN 102 0.0006
645 FLUID RETENTION 28 0.0005
646 BONE PAIN 32 0.0005
647 CHILLS 64 0.0005
648 HEART RATE INCREASED 54 0.0005
649 WHITE BLOOD CELL COUNT DECREASED 59 0.0005
650 PSYCHOTIC DISORDER 16 0.0005
651 FOOT DEFORMITY 6 0.0005
652 ARTHROPATHY 30 0.0005
653 NERVE INJURY 6 0.0005
654 HERPES ZOSTER 31 0.0005
655 LOCALISED INFECTION 13 0.0005
656 SWELLING FACE 35 0.0005
657 IMMUNODEFICIENCY 8 0.0005
658 ALOPECIA 105 0.0005
659 JOINT STIFFNESS 14 0.0005
660 BLOOD CALCIUM DECREASED 6 0.0005
661 ANHEDONIA 14 0.0005
662 DYSPNOEA EXERTIONAL 20 0.0005
663 PULMONARY CONGESTION 7 0.0005
664 REBOUND EFFECT 6 0.0005
665 INTESTINAL OBSTRUCTION 20 0.0005
666 DISORIENTATION 21 0.0005
667 SEPTIC SHOCK 23 0.0005
668 FOOT FRACTURE 10 0.0005
669 MYOCARDIAL ISCHAEMIA 6 0.0005
670 HAEMORRHAGE 55 0.0005
671 OSTEONECROSIS OF JAW 13 0.0005
672 SKIN IRRITATION 24 0.0005
673 GASTRIC HAEMORRHAGE 6 0.0005
674 HYPERGLYCAEMIA 19 0.0005
675 WHITE BLOOD CELL COUNT INCREASED 20 0.0005
676 PNEUMONIA ASPIRATION 13 0.0005
677 SEPSIS 58 0.0005
678 FREQUENT BOWEL MOVEMENTS 14 0.0005
679 RENAL DISORDER 24 0.0005
680 VASCULITIS 6 0.0005
681 RASH MACULAR 18 0.0005
682 EAR PAIN 10 0.0005
683 IRRITABLE BOWEL SYNDROME 11 0.0005
684 FUNGAL INFECTION 17 0.0005
685 HEADACHE 317 0.0005
686 INFLAMMATION 26 0.0005
687 COORDINATION ABNORMAL 7 0.0005
688 SPINAL FRACTURE 10 0.0005
689 SENSORY DISTURBANCE 8 0.0005
690 DYSPEPSIA 49 0.0005
691 APHASIA 15 0.0005
692 MUSCLE SPASMS 91 0.0005
693 INTERSTITIAL LUNG DISEASE 24 0.0005
694 ANXIETY 141 0.0005
695 PALPITATIONS 58 0.0005
696 ABDOMINAL DISCOMFORT 83 0.0005
697 DIALYSIS 7 0.0005
698 BACK DISORDER 8 0.0005
699 RESTLESSNESS 18 0.0005
700 CYTOPENIA 6 0.0005
701 CHEST DISCOMFORT 50 0.0005
702 GLOMERULAR FILTRATION RATE DECREASED 6 0.0005
703 PLASMA CELL MYELOMA 19 0.0005
704 PARAESTHESIA ORAL 7 0.0005
705 MYELODYSPLASTIC SYNDROME 7 0.0005
706 DEPRESSION 110 0.0005
707 HYPOKINESIA 7 0.0005
708 PRURITUS 185 0.0005
709 HYPERHIDROSIS 62 0.0005
710 MALAISE 211 0.0005
711 THROAT TIGHTNESS 13 0.0005
712 OXYGEN SATURATION DECREASED 27 0.0005
713 INJECTION SITE DISCOLOURATION 6 0.0005
714 PULMONARY HYPERTENSION 10 0.0005
715 RESPIRATORY FAILURE 35 0.0005
716 MUSCULOSKELETAL STIFFNESS 42 0.0005
717 CARDIO-RESPIRATORY ARREST 20 0.0005
718 SINUSITIS 49 0.0005
719 BLOOD UREA INCREASED 8 0.0005
720 OFF LABEL USE 418 0.0005
721 OROPHARYNGEAL PAIN 44 0.0005
722 FACE OEDEMA 8 0.0005
723 FEELING HOT 29 0.0005
724 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 8 0.0005
725 COLON CANCER 7 0.0005
726 HYPOTHYROIDISM 15 0.0005
727 RETCHING 10 0.0005
728 MENTAL STATUS CHANGES 13 0.0005
729 THERAPEUTIC RESPONSE UNEXPECTED 21 0.0005
730 VOMITING 220 0.0005
731 THERAPY CESSATION 24 0.0005
732 DYSKINESIA 19 0.0005
733 SCAR 8 0.0005
734 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 12 0.0005
735 GASTRIC DISORDER 16 0.0005
736 UNDERDOSE 34 0.0005
737 DISEASE PROGRESSION 55 0.0005
738 RENAL IMPAIRMENT 39 0.0005
739 RASH GENERALISED 12 0.0005
740 NAUSEA 366 0.0005
741 SKIN EXFOLIATION 39 0.0005
742 ARTHRALGIA 192 0.0005
743 THERAPY INTERRUPTED 33 0.0005
744 BLOOD GLUCOSE INCREASED 87 0.0005
745 PRODUCT DISPENSING ERROR 10 0.0005
746 PRODUCT PRESCRIBING ISSUE 10 0.0005
747 INTENTIONAL PRODUCT MISUSE 40 0.0005
748 IMPAIRED HEALING 15 0.0005
749 BEDRIDDEN 6 0.0005
750 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 25 0.0005
751 TOOTH INFECTION 6 0.0005
752 ABNORMAL BEHAVIOUR 18 0.0005
753 APPLICATION SITE PAIN 10 0.0005
754 ADVERSE REACTION 6 0.0005
755 TENDONITIS 7 0.0005
756 ABDOMINAL PAIN UPPER 93 0.0005
757 EAR INFECTION 12 0.0005
758 SKIN DISORDER 15 0.0004
759 CARDIAC DISORDER 42 0.0004
760 LUNG DISORDER 22 0.0004
761 NECK PAIN 25 0.0004
762 THROMBOCYTOPENIA 50 0.0004
763 SNEEZING 10 0.0004
764 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 90 0.0004
765 BONE MARROW FAILURE 9 0.0004
766 WEIGHT INCREASED 99 0.0004
767 BLOOD LACTATE DEHYDROGENASE INCREASED 7 0.0004
768 DISEASE RECURRENCE 21 0.0004
769 TACHYPNOEA 6 0.0004
770 SPEECH DISORDER 23 0.0004
771 SKIN LESION 12 0.0004
772 FEBRILE NEUTROPENIA 29 0.0004
773 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 8 0.0004
774 MOVEMENT DISORDER 14 0.0004
775 MYOCARDIAL INFARCTION 76 0.0004
776 INFECTION 63 0.0004
777 PAIN 267 0.0004
778 NIGHT SWEATS 14 0.0004
779 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 78 0.0004
780 PLATELET COUNT DECREASED 46 0.0004
781 BLOOD POTASSIUM INCREASED 7 0.0004
782 HAEMOPTYSIS 12 0.0004
783 TREMOR 71 0.0004
784 PRODUCT USE IN UNAPPROVED INDICATION 106 0.0004
785 BLISTER 24 0.0004
786 INCORRECT DRUG ADMINISTRATION DURATION 12 0.0004
787 GASTROINTESTINAL DISORDER 38 0.0004
788 CARDIAC ARREST 35 0.0004
789 PAIN IN JAW 12 0.0004
790 DRUG LEVEL INCREASED 7 0.0004
791 SINUS TACHYCARDIA 6 0.0004
792 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 30 0.0004
793 PULMONARY EMBOLISM 40 0.0004
794 MUCOSAL INFLAMMATION 11 0.0004
795 COMA 20 0.0004
796 LIVER FUNCTION TEST INCREASED 9 0.0004
797 CARDIOGENIC SHOCK 6 0.0004
798 BLOOD GLUCOSE DECREASED 20 0.0004
799 TYPE 2 DIABETES MELLITUS 14 0.0004
800 CANDIDA INFECTION 7 0.0004
801 MEDICATION ERROR 23 0.0004
802 HERNIA 8 0.0004
803 PRESCRIBED OVERDOSE 8 0.0004
804 CRYING 15 0.0004
805 LIVER FUNCTION TEST ABNORMAL 12 0.0004
806 MENTAL IMPAIRMENT 10 0.0004
807 HYPOGLYCAEMIA 20 0.0004
808 C-REACTIVE PROTEIN INCREASED 15 0.0004
809 INTENTIONAL PRODUCT USE ISSUE 36 0.0004
810 ACCIDENTAL OVERDOSE 15 0.0004
811 UNEVALUABLE EVENT 31 0.0004
812 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 7 0.0004
813 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 29 0.0004
814 PARAESTHESIA 64 0.0004
815 TRANSAMINASES INCREASED 9 0.0004
816 WHEEZING 24 0.0004
817 DISABILITY 8 0.0004
818 ACTIVITIES OF DAILY LIVING IMPAIRED 8 0.0004
819 SINUS DISORDER 8 0.0004
820 RESPIRATORY DISORDER 12 0.0004
821 ABDOMINAL PAIN 93 0.0004
822 AGGRESSION 20 0.0004
823 NEUROTOXICITY 7 0.0004
824 PRODUCT SUBSTITUTION ISSUE 23 0.0004
825 PRODUCT USE ISSUE 75 0.0004
826 RESPIRATORY DISTRESS 11 0.0004
827 PRODUCT DOSE OMISSION ISSUE 117 0.0004
828 RASH 173 0.0004
829 COLITIS 15 0.0004
830 DEVICE FAILURE 6 0.0004
831 WOUND 11 0.0004
832 MULTIPLE ORGAN DYSFUNCTION SYNDROME 11 0.0004
833 ILLNESS 40 0.0004
834 EJECTION FRACTION DECREASED 6 0.0004
835 RESTLESS LEGS SYNDROME 7 0.0004
836 THERAPY PARTIAL RESPONDER 6 0.0004
837 TREATMENT NONCOMPLIANCE 21 0.0004
838 FLUSHING 39 0.0004
839 PYREXIA 132 0.0004
840 DRUG DOSE OMISSION 63 0.0004
841 BLOOD GLUCOSE ABNORMAL 7 0.0004
842 PNEUMOTHORAX 6 0.0004
843 CELLULITIS 19 0.0004
844 BLOOD BILIRUBIN INCREASED 10 0.0004
845 INJURY 26 0.0004
846 FRACTURE 7 0.0004
847 PROTEINURIA 7 0.0004
848 NEUTROPHIL COUNT DECREASED 15 0.0004
849 MUSCULOSKELETAL DISORDER 7 0.0004
850 ADVERSE DRUG REACTION 33 0.0004
851 CHOLELITHIASIS 12 0.0004
852 DRUG PRESCRIBING ERROR 7 0.0004
853 STAPHYLOCOCCAL INFECTION 12 0.0004
854 TOOTH DISORDER 8 0.0004
855 PANCREATITIS 19 0.0004
856 ORAL HERPES 7 0.0004
857 SURGERY 21 0.0004
858 RASH PAPULAR 8 0.0004
859 PANCREATITIS ACUTE 8 0.0004
860 ABDOMINAL PAIN LOWER 9 0.0004
861 HEMIPARESIS 6 0.0004
862 CEREBROVASCULAR ACCIDENT 60 0.0004
863 DRY SKIN 47 0.0004
864 INJECTION SITE BRUISING 28 0.0004
865 NASOPHARYNGITIS 64 0.0003
866 PRODUCT PHYSICAL ISSUE 7 0.0003
867 PANCREATIC CARCINOMA 10 0.0003
868 PERICARDIAL EFFUSION 8 0.0003
869 NEUTROPENIA 47 0.0003
870 NEEDLE ISSUE 10 0.0003
871 BODY TEMPERATURE INCREASED 7 0.0003
872 DEVICE USE ISSUE 6 0.0003
873 COLD SWEAT 6 0.0003
874 LABORATORY TEST ABNORMAL 10 0.0003
875 PSORIASIS 44 0.0003
876 GALLBLADDER DISORDER 6 0.0003
877 PRODUCT PRESCRIBING ERROR 8 0.0003
878 THERAPEUTIC PRODUCT EFFECT DECREASED 15 0.0003
879 JAUNDICE 9 0.0003
880 GASTROENTERITIS VIRAL 6 0.0003
881 COVID-19 58 0.0003
882 NEURALGIA 8 0.0003
883 RHEUMATOID ARTHRITIS 37 0.0003
884 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 11 0.0003
885 MIGRAINE 31 0.0003
886 UPPER RESPIRATORY TRACT INFECTION 15 0.0003
887 INCORRECT PRODUCT ADMINISTRATION DURATION 7 0.0003
888 DERMATITIS ATOPIC 17 0.0003
889 MENTAL DISORDER 14 0.0003
890 SEIZURE 37 0.0003
891 HEPATIC CIRRHOSIS 6 0.0003
892 PRODUCT DOSE OMISSION IN ERROR 9 0.0003
893 ILL-DEFINED DISORDER 19 0.0003
894 HOSPITALISATION 48 0.0003
895 GENERAL PHYSICAL HEALTH DETERIORATION 36 0.0003
896 EXPOSURE VIA SKIN CONTACT 8 0.0003
897 DEEP VEIN THROMBOSIS 20 0.0003
898 ANAPHYLACTIC REACTION 17 0.0003
899 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 9 0.0003
900 SKIN FISSURES 6 0.0003
901 ASCITES 9 0.0003
902 ELECTROCARDIOGRAM QT PROLONGED 11 0.0003
903 SEDATION 8 0.0003
904 INFLUENZA 34 0.0003
905 DRUG EFFECT INCOMPLETE 11 0.0003
906 INFUSION RELATED REACTION 20 0.0003
907 PRESCRIBED UNDERDOSE 6 0.0003
908 VIRAL INFECTION 10 0.0003
909 DISTURBANCE IN ATTENTION 16 0.0003
910 TOXICITY TO VARIOUS AGENTS 50 0.0003
911 HEPATIC ENZYME INCREASED 20 0.0003
912 DEATH 252 0.0003
913 LUNG NEOPLASM MALIGNANT 12 0.0003
914 DIABETIC KETOACIDOSIS 7 0.0003
915 FIBROMYALGIA 7 0.0003
916 NEOPLASM PROGRESSION 10 0.0003
917 ROAD TRAFFIC ACCIDENT 12 0.0003
918 WITHDRAWAL SYNDROME 12 0.0003
919 SUICIDAL IDEATION 26 0.0003
920 LYMPHADENOPATHY 10 0.0003
921 MOOD SWINGS 9 0.0003
922 NO ADVERSE EVENT 51 0.0003
923 IMPAIRED WORK ABILITY 6 0.0003
924 LEUKOPENIA 14 0.0003
925 DRUG EFFECT DECREASED 15 0.0003
926 LACTIC ACIDOSIS 9 0.0003
927 PRODUCT STORAGE ERROR 24 0.0003
928 BLADDER CANCER 16 0.0003
929 PSORIATIC ARTHROPATHY 11 0.0003
930 FOETAL EXPOSURE DURING PREGNANCY 22 0.0003
931 STEVENS-JOHNSON SYNDROME 6 0.0003
932 URTICARIA 45 0.0003
933 DEVICE ISSUE 24 0.0003
934 THERAPEUTIC RESPONSE DECREASED 16 0.0003
935 SHOCK 6 0.0003
936 PAIN OF SKIN 7 0.0003
937 PALLOR 7 0.0003
938 MOOD ALTERED 7 0.0003
939 PANCYTOPENIA 14 0.0003
940 ANGIOEDEMA 11 0.0002
941 ECZEMA 13 0.0002
942 WRONG TECHNIQUE IN DRUG USAGE PROCESS 9 0.0002
943 PRODUCT COMPLAINT 6 0.0002
944 CARDIOVASCULAR DISORDER 6 0.0002
945 MALIGNANT NEOPLASM PROGRESSION 24 0.0002
946 RESPIRATORY TRACT INFECTION 6 0.0002
947 INJECTION SITE RASH 7 0.0002
948 DRUG WITHDRAWAL SYNDROME 20 0.0002
949 INJECTION SITE PRURITUS 15 0.0002
950 COLITIS ULCERATIVE 10 0.0002
951 SKIN BURNING SENSATION 16 0.0002
952 APPLICATION SITE PRURITUS 5 0.0002
953 PANIC ATTACK 8 0.0002
954 INFLUENZA LIKE ILLNESS 18 0.0002
955 MATERNAL EXPOSURE DURING PREGNANCY 19 0.0002
956 INJECTION SITE HAEMORRHAGE 17 0.0002
957 THERAPEUTIC RESPONSE SHORTENED 7 0.0002
958 NEOPLASM MALIGNANT 14 0.0002
959 INJECTION SITE PAIN 64 0.0002
960 BLOOD CREATINE PHOSPHOKINASE INCREASED 6 0.0002
961 ADVERSE EVENT 19 0.0002
962 MULTIPLE SCLEROSIS RELAPSE 14 0.0002
963 AGITATION 15 0.0002
964 ACUTE MYOCARDIAL INFARCTION 6 0.0002
965 DEVICE MALFUNCTION 14 0.0002
966 EMOTIONAL DISTRESS 24 0.0002
967 ACNE 15 0.0002
968 INCORRECT ROUTE OF DRUG ADMINISTRATION 7 0.0002
969 PROSTATE CANCER 15 0.0002
970 IRRITABILITY 11 0.0002
971 INJECTION SITE SWELLING 14 0.0002
972 OSTEONECROSIS 6 0.0002
973 LIVER DISORDER 8 0.0002
974 INJECTION SITE REACTION 12 0.0002
975 ASPARTATE AMINOTRANSFERASE INCREASED 9 0.0002
976 SYSTEMIC LUPUS ERYTHEMATOSUS 6 0.0002
977 PRODUCT ADHESION ISSUE 6 0.0002
978 HEPATIC FUNCTION ABNORMAL 6 0.0002
979 INJECTION SITE ERYTHEMA 19 0.0002
980 ABORTION SPONTANEOUS 6 0.0001
981 ALANINE AMINOTRANSFERASE INCREASED 9 0.0001
982 EXPOSURE DURING PREGNANCY 9 0.0001
983 DEVICE LEAKAGE 6 0.0001
984 VAGINAL HAEMORRHAGE 6 0.0001
985 DEVICE DISLOCATION 6 0.0001
986 MULTIPLE SCLEROSIS 6 0.0001
987 CONVULSION 7 0.0001
988 OVERDOSE 26 0.0001
989 SUICIDE ATTEMPT 7 0.0001
990 BREAST CANCER 9 0.0001